APPLICATIONS PUBLISHED 26 MARCH 2003
Published: 1-Sep-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Use of EGF-R protein tyrosine kinase inhibitors for preventing photoaging in human skin
The Regents of the University of Michigan 1294349*
Use of calcium-releasing or binding substances for the specific attentuation or strengthening of the barrier function of the skin
Beiersdorf 1294351*
Use of insulins and insulin derivatives
Cognis Deutschland 1294354*
Use of inulin and inulin derivatives
Cognis Deutschland 1294355*
Sustained release delivery systems for solutes
Farrington Pharmaceuticals 1294356*
Bioavailable dosage form of isotretinoin
Ranbaxy Laboratories 1294357*
Wet milling process
SmithKline Beecham 1294358*
Process for preparing and harvesting crystalline particles
Glaxo Group 1294359*
Novel process for preparing and harvesting crystalline particles
Glaxo Group 1294360*
Compsn and methods to improve the oral absorption of antimicrobial agents
Cubist Pharmaceuticals; International Health Management Associates; The University of Utah Research Foundation 1294361*
Novel process for preparing crystalline particles
Glaxo Group 1294362*
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
DepoMed 1294363*
Stable gabapentin having pH within a controlled range
Teva Pharmaceutical Industries 1294364*
Cytotoxic agents comprising single-stranded and/or looped DNA
BTG International 1294365*
Pharmaceutical compounds for treating COPD
AstraZeneca 1294366*
Oral compsns comprising host-response modulating agent
Procter & Gamble 1294367*
Management of snoring by oral administration of dimethyl sulphone
Elstan Corp 1294368*
Novel formulations of (a)-2,4-disulphophenyl-N-tert-butylnitrone
AstraZeneca 1294369*
Triterpenoid derivatives
Univerzita palackeho V Olomouci 1294370*
Medium chain fatty acids applicable as antimicrobial agents
NV Seghers Nutrition Sciences 1294371*
Dry powder formulation comprising racecadotril
Bioproject 1294372*
Pharmaceutical disinfectants comprising usnic acid and essential oils
AD "Zdravlje" 1294373*
Flavone/flavanone derivatives for the systemic treatment and prophylaxis of UV-induced dermatoses
Krutmann, Jean; Stege, Helger 1294374*
Method of treatment of seborrheic dermatitis
Parks, L Dean 1294375*
Medicament for combating respiratory depression
Gruenenthal 1294376*
Methods and compsns for the treatment of alcoholism and alcohol dependence
Cardiff and Vale National Health Service Trust 1294377*
Thrombopoietin mimetics
SmithKline Beecham 1294378*
A new use for deferiprone
Apotex 1294379*
A method for treating septic shock
Orion Corp 1294380*
Neuroprotective 7-beta-hydrosteroids
Hunter-Fleming 1294381*
7-hydroxyepiandrosterone having neuroprotective activity
Hunter-Fleming 1294382*
Oral compsns comprising anti-microbial agents
Procter & Gamble 1294383*
Use of lanthanum compounds for the treatment of bone diseases
Shire Holdings 1294384*
Method for the production of artificial oxygen carriers from covalently cross-linking haemoglobin with improved functional properties of haemoglobin by cross-linking in the presence of chemically non-reacting effectors of the oxygen affinity of the haemoglobin
SanguiBioTech 1294385*
Synthetic oxygen transport made from cross-linked modified human or porcine haemoglobin with improved properties, method for a preparation thereof from purified material and use thereof
SanGuiBioTech 1294386*
Use of Phyllanthus constituents for treating or preventing infections caused by flaviviridae
CMI-Centers for Medical Innovation 1294387*
Extracts from Sophora species, method for producing the same and their use
Dr Wilmar Schwabe 1294388*
Therapeutic use of Sophora flavescens or Sophora subprostrata extracts
Dr Wilmar Schwabe 1294389*
The use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy
Yeda Research and Development Company 1294390*
Method of regulating a cell-mediated immune response by blocking lymphocytic cells and by blocking FA-1 mediated adhesion
Bristol-Myers Squibb 1294391*
Materials and methods relating for the treatment and diagnosis of pre-eclampsia
University College London 1294392*
Glycosylphosphatidylinositol specific phospholipase D proteins for the treatment and diagnosis of atherosclerosis
University College London 1294393*
A combination product comprising melagatran and a factor XA inhibitor
AstraZeneca 1294394*
A combination product comprising melagatran and a factor VIIA inhibitor
AstraZeneca 1294395*
Contraceptive vaccines for pest control
University of Sheffield 1294396*
Therapeutic method and compsn utilising antigen-antibody complexation and presentation by dentritic cells
Altarex Corp 1294397*
Therapeutic method and compsn utilising antigen-antibody complexation and presentation by dendritic cells
Altarex Corp 1294398*
Methods and compsn for oral vaccination
Wyeth 1294399*
Vaccine against foot-and-mouth disease
Merial 1294400*
Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake inhibitors
Lexigen Pharmaceuticals 1294401*
Compounds with a sulphonamide group and pharmaceutical compsns containing these compounds
Schering 1294402*
Tripeptide prodrug compounds
Corixa 1294403*
Prodrug compounds with an oligopeptide having an isoleucine residue
Corixa 1294404*
Prodrug compounds cleavable by thimet oligopeptide
Corixa 1294405*
Modulation of chromosome function by chromatin modelling agents
Universite de Geneve 1294406*
Dual recombinant gene therapy compsns and methods of use
Collateral Therapeutics 1294407*
Rhodamine diagnostic agent and diagnostic methods for epithelial cancer
Zila 1294408*
Membrane-permeant peptide complexes for medical imaging
Washington University 1294409*
Process and compsn for cleaning medical instruments
Novapharm 1294410*
A novel treatment for cough
The Regents of the University of California 1294411*
Method of using lectins for contraception and prophylaxis against diseases transmittable by sexual contact and condom containing lectin
Legere Pharmaceuticals 1294412*
Sprayable wound healing compsns
Bristol-Myers Squibb 1294413*
Compsn and method for the repair and regeneration of cartilage and other tissues
Biosyntech Canada 1294414*
A dual-purpose device for drug delivery and secretion collection and methods for using the same
Medihale 1294415*
